Sources: FDA Drug Safety Communication, Jan 13, 2026 FDA prescribing labels: Ozempic, Wegovy, Mounjaro, Zepbound EMA / PRAC statement on NAION, June 6, 2025 UK MHRA Drug Safety Update on semaglutide & NAION Endocrine Society of India Clinical Practice Guidelines for Obesity, 2025 Disclaimer: This content is for educational purposes only and is not medical advice, diagnosis, or treatment
Clinical manifestation and classification of ulcerative colitis
Philadelphia: WB Saunders
[PMID: 2031877] PubMed record related to this compound for laboratory literature review
IQVIA estimates the UK will be a market of over 2 billion for GLP-1 treatments by the end of 2025, irrespective of that price shock